Angiosome: Is It Feasible in Critical Limb Ischemia?

Courtesy of Dr. Carlos Fava.

 

Angiosome Critical Limb Ischemia

Critical limb ischemia (CLI) accompanied by tissue loss entails high risk of amputation. At present, there is substantial evidence in favor of revascularization by PCI according to the angiosome concept, but the feasibility of this treatment remains unclear.

 

161 compromised limbs were analyzed in 160 patients with foot ulcers undergoing below-the-knee (BTK) interventions. Mean age was 75, and 67% of patients were diabetic. They were all 5 or 6 Rutherford stage.

 

Lesions were associated to:

  • Only one angiosome in 39 patients (24%)
  • 2 angiosomes in 75 patients (46.6%)
  • 3 angiosomes in 42 patients (26.1%)
  • 4 angiosomes in 4 patients (2.5%)
  • 5 angiosomes in 1 patient (0.6%)

 

Direct flow to the affected angiosome was achieved in 98 patients (60.9%). Researchers analyzed the number of angiosomes associated to ulcers and revascularization success rate. If ulcers were associated to:

  • 1 angiosome, revascularization was successful in 27 patients (69.2%)
  • 2 angiosomes, it was successful in 65 patients (86.7%)
  • 3 angiosomes, it was successful in 36 patients (85.7%)
  • 4 angiosomes, it was successful in 1 patient (25%)
  • 5 angiosomes, there was no chance of revascularization

 

Conclusion

In critical limb ischemia, tissue lesions mostly affect several angiosomes. In the literature published so far, there is evidence on angiosome targeted revascularization when more than one angiosome is compromised and we need consensus to achieve an exact definition.

 

Editorial Comment

Cases of CLI are dramatically increasing, and they are accompanied by a significant rate of amputation.

Multiple publications have shown the benefits of the angiosome concept and this analyzis shows it is feasible in little more than half of patients.

 

We should incorporate the concept of angiosome targeted revascularization in CLI knowing that it involves longer procedural time, the need of new strategies and new materials to become more effective with this group of patients.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: The Feasibility of Angisome-Targeted Endovascular Treatment in Patients with Critical Limb Ischemia and Foot Ulcer.

Reference: Kristýna Spillerová et al. Ann Vasc Surg 2016;30:20-70-276.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...